| 044 Chronic ER stress promotes cGAS/mtDNA-induced autoimmunity via ATF6 in myotonic dystrophy type 2 S Rösing, F Ullrich, S Meisterfeld, F Schmidt, N Eberl, J Wegner, M Schlee, ... Journal of Investigative Dermatology 143 (5), S8, 2023 | | 2023 |
| 15 RNA Interference in Scope of Immune System A Ablasser, G Hartmann, V Hornung NUCLEIC ACIDS, 207, 2008 | | 2008 |
| 5'-trifosfato-oligonucleótido con extremo romo y sus utilizaciones GPD Hartmann | | 2015 |
| 5'-TRIPHOSPHATE DSRNA-INDUCED STIMULATION OF RIG-I PREVENTS INFLUENZA H1N1 INFECTION OF PRIMARY NASAL EPITHELIAL CELL CULTURE AND PROTECTS MICE FROM INFECTION IN VIVO C Coch, V Stehle, B Kuemmerer, D Stabenow, JP Stuempel, J Dassler, ... NUCLEIC ACID THERAPEUTICS 21 (5), A48-A48, 2011 | | 2011 |
| 5'-Triphosphate RNA is the ligand for RIG-I V Hornung, J Ellegast, S Kim, K Brzózka, A Jung, H Kato, H Poeck, ... science 314 (5801), 994-997, 2006 | 3109 | 2006 |
| 5'-triphosphated siRNA activate RIG-I and control HBV replication G Ebert, H Poeck, G Hartmann, U Protzer HUMAN GENE THERAPY 20 (11), 1528-1529, 2009 | | 2009 |
| 5'Trip phosphate triphosphate oligonucleotide and uses thereof GPD Hartmann, MDRN Schlee | | 2015 |
| 5′ triphosphate oligonucleotide with blunt end and uses thereof G Hartmann, M Schlee US Patent 10,036,021, 2018 | | 2018 |
| 5′ triphosphate oligonucleotide with blunt end and uses thereof G Hartmann, M Schlee US Patent 10,196,638, 2019 | | 2019 |
| 5′ triphosphate oligonucleotide with blunt end and uses thereof G Hartmann, M Schlee US Patent 9,738,680, 2017 | 73* | 2017 |
| 5′ Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice G Ebert, H Poeck, J Lucifora, N Baschuk, K Esser, I Esposito, G Hartmann, ... Gastroenterology 141 (2), 696-706. e3, 2011 | 92 | 2011 |
| 5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma H Poeck, R Besch, C Maihoefer, M Renn, D Tormo, SS Morskaya, ... Nature medicine 14 (11), 1256-1263, 2008 | 484 | 2008 |
| A conserved histidine in the RNA sensor RIG-I controls immune tolerance to N1-2′ O-methylated self RNA C Schuberth-Wagner, J Ludwig, AK Bruder, AM Herzner, T Zillinger, ... Immunity 43 (1), 41-51, 2015 | 289 | 2015 |
| A conserved isoleucine in the binding pocket of RIG-I controls immune tolerance to mitochondrial RNA AK de Regt, K Anand, K Ciupka, K Gatterdam, B Putschli, D Fusshoeller, ... bioRxiv, 2022.08. 02.502180, 2022 | 3 | 2022 |
| A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test T Muley, X Zhang, S Holdenrieder, CM Korse, X Zhi, R Molina, Z Liu, ... Tumor Biology 42 (9), 1010428320958603, 2020 | 6 | 2020 |
| A Human In Vitro Whole Blood Assay to Predict the Systemic Cytokine Response to Therapeutic Oligonucleotides Including siRNA C Coch, C Lück, A Schwickart, B Putschli, M Renn, T Höller, W Barchet, ... PloS one 8 (8), e71057, 2013 | 54 | 2013 |
| A mammalian microRNA expression atlas based on small RNA library sequencing P Landgraf, M Rusu, R Sheridan, A Sewer, N Iovino, A Aravin, S Pfeffer, ... Cell 129 (7), 1401-1414, 2007 | 4480 | 2007 |
| A Message from the Oligonucleotide Therapeutics Society G Hartmann Nucleic Acid Therapeutics 22 (1), 1, 2012 | | 2012 |
| A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression T Tzaridis, J Weller, D Bachurski, F Shakeri, C Schaub, P Hau, A Buness, ... International Journal of Cancer 152 (2), 308-319, 2023 | 8 | 2023 |
| Absence of cGAS-mediated type I IFN responses in HIV-1–infected T cells C Elsner, A Ponnurangam, J Kazmierski, T Zillinger, J Jansen, D Todt, ... Proceedings of the National Academy of Sciences 117 (32), 19475-19486, 2020 | 29 | 2020 |
